Buprenorphine Detoxification With Two Types of Treatment. BBD III - 12

Completed · Phase 2

Conditions studied: Opioid-Related Disorders

In brief

The purpose of this study is to evaluate buprenorphine and behavioral treatment with and without contingent payment on compliance with naltrexone.

Key facts

Study ID

NCT00000230

Run by

University of Vermont

People needed

0

Starts

1995-01-01

Last updated by the study team

2016-05-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Treatment Research Center — Burlington, Vermont, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.